Gadolinium Information

OptiMARK (gadoversetamide), a gadolinium-based contrast agent which is commonly used to improve the visibility of internal structures when patients undergo an MRI has been linked to a serious, life-threatening disease known as Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD). If you or a loved one have had an MRI or MRA, and since [...]

Omniscan (gadodiamide), a gadolinium-based contrast agent which is commonly used to improve the visibility of internal structures when patients undergo an MRI has been linked to a serious, life-threatening disease known as Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD). If you or a loved one have had an MRI or MRA, and since [...]

A lawsuit was recently filed in US District Court by a former nurse charging that Omniscan was responsible for causing her to develop a serious skin and joint condition called Nephrogenic Systemic Fibrosis. This may be the first lawsuit filed against GE Healthcare, the manufacturer of Omniscan, as a result of adverse events related to [...]

ProHance is a MRI contrast agent manufactured by Bracco Diagnostics. It received approval from the US Food and Drug Administration in 1992 and was released to the retail market later that year. ProHance is used to enhance the images obtained by MRI procedures and is used to detail any abnormal tissue in the brain, spine, [...]

OptiMARK is a Gadolinium based contrast agent used to enhance the images obtained by MRI procedures. Also known as Gadoversetamide, the agent is manufactured by Mallinckrodt, which is a division of Tyco Healthcare. OptiMARK is considered a paramagnetic MRI contrast agent and is used to increase the detail of MRI images of the brain, spine, [...]

Omniscan was created as a contrast agent for use in Magnetic Resonance Imaging (MRI) procedures and was approved for use by the US Food and Drug Administration in 1993. Also known as Gadodiamide, the agent is considered a paramagnetic agent that tends to generate a localized magnetic field. When protons move through this field, the [...]

MultiHance is manufactured by Bracco Diagnostics based out of Princeton, New Jersey. Also known as Gadobenate dimeglumine, the contrast agent was approved by the US Food and Drug Administration for use in enhancing MRI images on November 23, 2004. MultiHance is considered a paramagnetic MRI contrast agent meaning that it tends to follow magnetic fields [...]

MultiHance (gadobenate dimeglumine), a gadolinium-based contrast agent which is commonly used to improve the visibility of internal structures when patients undergo an MRI has been linked to a serious, life-threatening disease known as Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD). If you or a loved one have had an MRI or MRA, and [...]

The first cases of Nephrogenic Systemic Fibrosis were discovered in 1997 with the first medical references detailing the condition written in 2000. The condition only affects individuals with impaired renal function or renal failure and causes the skin and connective tissues in the body to thicken and harden. The typical symptoms of Nephrogenic Systemic Fibrosis [...]

Magnevist was the first Gadolinium based contrast agent approved for use in the United States by the US Food and Drug Administration. Introduced in 1988, the contrast agent has been used in more than 80 million applications worldwide. As the first contrast agent approved for use in enhancing MRI images, Magnevist is still considered an [...]